Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
CPP Investments posts C$17bn quarterly gain as Fund reaches C$777.5bn
CPP Investments posts C$17bn quarterly gain as Fund reaches C$777.5bn CPP Investments reported net assets of C$777.5bn at the end of the second quarter of fiscal 2026, up from C$760.5bn in the previous quarter. The Fund delivered a net return of C$17bn, or 2.7%,...
Why Europe’s private equity firms are abandoning the generalist playbook
Why Europe’s private equity firms are abandoning the generalist playbook European private equity has gone through a decade in which capital inflows masked weakened differentiation. As a result, firms are now being forced to decide what they actually stand for. The...
KKR provides $750m in private credit to support Chandra Asri’s Esso deal
KKR provides $750m in private credit to support Chandra Asri’s Esso deal KKR has agreed to provide $750m in financing to support Chandra Asri Group’s acquisition of Exxon Mobil’s Esso-branded retail fuel stations in Singapore, marking another significant deployment...